172 related articles for article (PubMed ID: 34612504)
1. Persistence of post-COVID lung parenchymal abnormalities during the three-month follow-up.
Zubairi ABS; Shaikh A; Zubair SM; Ali AS; Awan S; Irfan M
Adv Respir Med; 2021; 89(5):477-483. PubMed ID: 34612504
[TBL] [Abstract][Full Text] [Related]
2. Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment.
Myall KJ; Mukherjee B; Castanheira AM; Lam JL; Benedetti G; Mak SM; Preston R; Thillai M; Dewar A; Molyneaux PL; West AG
Ann Am Thorac Soc; 2021 May; 18(5):799-806. PubMed ID: 33433263
[No Abstract] [Full Text] [Related]
3. Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge.
Liang L; Yang B; Jiang N; Fu W; He X; Zhou Y; Ma WL; Wang X
J Korean Med Sci; 2020 Dec; 35(47):e418. PubMed ID: 33289374
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary fibrosis and its related factors in discharged patients with new corona virus pneumonia: a cohort study.
Li X; Shen C; Wang L; Majumder S; Zhang D; Deen MJ; Li Y; Qing L; Zhang Y; Chen C; Zou R; Lan J; Huang L; Peng C; Zeng L; Liang Y; Cao M; Yang Y; Yang M; Tan G; Tang S; Liu L; Yuan J; Liu Y
Respir Res; 2021 Jul; 22(1):203. PubMed ID: 34243776
[TBL] [Abstract][Full Text] [Related]
5. Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis.
Fabbri L; Moss S; Khan FA; Chi W; Xia J; Robinson K; Smyth AR; Jenkins G; Stewart I
Thorax; 2023 Feb; 78(2):191-201. PubMed ID: 35338102
[TBL] [Abstract][Full Text] [Related]
6. Persistent pulmonary abnormalities after 18 months of SARS-CoV-2 pneumonia.
Valenzuela C; de la Fuente L; Hernández S; Olivera MJ; Molina C; Montes N; Benavides C; Caballero P
Radiologia (Engl Ed); 2024 Apr; 66 Suppl 1():S47-S56. PubMed ID: 38642961
[TBL] [Abstract][Full Text] [Related]
7. Prediction of the Development of Pulmonary Fibrosis Using Serial Thin-Section CT and Clinical Features in Patients Discharged after Treatment for COVID-19 Pneumonia.
Yu M; Liu Y; Xu D; Zhang R; Lan L; Xu H
Korean J Radiol; 2020 Jun; 21(6):746-755. PubMed ID: 32410413
[TBL] [Abstract][Full Text] [Related]
8. Chest CT Lung Abnormalities 1 Year after COVID-19: A Systematic Review and Meta-Analysis.
Bocchino M; Rea G; Capitelli L; Lieto R; Bruzzese D
Radiology; 2023 Jul; 308(1):e230535. PubMed ID: 37404150
[TBL] [Abstract][Full Text] [Related]
9. Analysis of thin-section CT in patients with coronavirus disease (COVID-19) after hospital discharge.
Wei J; Yang H; Lei P; Fan B; Qiu Y; Zeng B; Yu P; Lv J; Jian Y; Wan C
J Xray Sci Technol; 2020; 28(3):383-389. PubMed ID: 32474479
[TBL] [Abstract][Full Text] [Related]
10. [The diagnostic value of CT-guided percutaneous needle lung biopsy in diffuse parenchymal lung diseases].
Peng M; Xu WB; Shi JH; Cai BQ; Tian XL; Liu T; Zhang H; Xiao Y; Liu W; Feng RE; Liu HR; Zhu YJ
Zhonghua Jie He He Hu Xi Za Zhi; 2012 Mar; 35(3):171-5. PubMed ID: 22781147
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of pulmonary residuals as one of the sequelae of COVID-19 and it's predictors among moderate and severe cases.
Abdel-Hamid HM; Rizk HI; Magdy S
Indian J Tuberc; 2021 Oct; 68(4):450-456. PubMed ID: 34752312
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary function and chest computed tomography abnormalities 6-12 months after recovery from COVID-19: a systematic review and meta-analysis.
Lee JH; Yim JJ; Park J
Respir Res; 2022 Sep; 23(1):233. PubMed ID: 36068582
[TBL] [Abstract][Full Text] [Related]
13. [Parenchymal lung changes on CT in patients with coronavirus disease 2019 (COVID-19)].
Halldorsson AB; Axelsson GT; Jonsson HM; Isaksson JD; Hardardottir H; Gudmundsson G; Hansdottir S
Laeknabladid; 2021 Oct; 107(10):460-468. PubMed ID: 34585672
[TBL] [Abstract][Full Text] [Related]
14. Factors Affecting the Risk of Interstitial Lung Disease Development in Hospitalized Patients With COVID-19 Pneumonia.
Polat G; Özdemir Ö; Ermin S; Unat DS; Şahin GV; Türk MA; Güldaval F; Susam S; Kıraklı C
Respir Care; 2022 Oct; 67(10):1272-1281. PubMed ID: 35790396
[TBL] [Abstract][Full Text] [Related]
15. Interstitial lung abnormalities and pulmonary fibrosis in COVID-19 patients: a short-term follow-up case series.
Gulati A; Lakhani P
Clin Imaging; 2021 Sep; 77():180-186. PubMed ID: 33836413
[TBL] [Abstract][Full Text] [Related]
16. Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae.
Froidure A; Mahsouli A; Liistro G; De Greef J; Belkhir L; Gérard L; Bertrand A; Koenig S; Pothen L; Yildiz H; Mwenge B; Aboubakar F; Gohy S; Pilette C; Reychler G; Coche E; Yombi JC; Ghaye B
Respir Med; 2021 May; 181():106383. PubMed ID: 33839588
[TBL] [Abstract][Full Text] [Related]
17. Fibrotic Interstitial Lung Abnormalities at 1-year Follow-up CT after Severe COVID-19.
Han X; Fan Y; Alwalid O; Zhang X; Jia X; Zheng Y; Shi H
Radiology; 2021 Dec; 301(3):E438-E440. PubMed ID: 34313470
[TBL] [Abstract][Full Text] [Related]
18. Chest CT features and functional correlates of COVID-19 at 3 months and 12 months follow-up.
Kumar K; Ratnakumar R; Collin SM; Berrocal-Almanza LC; Ricci P; Al-Zubaidy M; Coker RK; Coleman M; Elkin SL; Mallia P; Meghji J; Ross C; Russell GK; Ward K; Wickremasinghe M; Sheard S; Copley SJ; Kon OM
Clin Med (Lond); 2023 Sep; 23(5):467-477. PubMed ID: 37775167
[TBL] [Abstract][Full Text] [Related]
19. Radiological and functional lung sequelae of COVID-19: a systematic review and meta-analysis.
So M; Kabata H; Fukunaga K; Takagi H; Kuno T
BMC Pulm Med; 2021 Mar; 21(1):97. PubMed ID: 33752639
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary Function and Chest Computed Tomography (CT) Scan Findings After Antifibrotic Treatment for COVID-19-Related Pulmonary Fibrosis.
Lomanta JMJ; Quinto ML; Urquiza SC; Santiaguel JM
Am J Case Rep; 2022 Feb; 23():e934830. PubMed ID: 35152259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
